Don't Wait For New Covid Vaccine: Pharmacists

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2021-12-05 HKT 15:59

Share this story

facebook

  • The president of the Society of Hospital Pharmacists of Hong Kong, William Chui (right), says the government should considering buying the Sinopharm vaccine. Photo: RTHK

    The president of the Society of Hospital Pharmacists of Hong Kong, William Chui (right), says the government should considering buying the Sinopharm vaccine. Photo: RTHK

Pharmacists on Sunday advised people not to wait for a second generation vaccine as the Omicron coronavirus variant continues to spread across the globe.

The call comes as about four out of 10 people polled by the Society of Hospital Pharmacists of Hong Kong said they still haven't been vaccinated.

About 5,600 people were quizzed by the group in October.

More than half of those who expressed an intention to eventually get inoculated said they are still waiting for a better vaccine to come, while others thought it wasn't urgent.

But the society's president, William Chui, urged people to reconsider their decision.

"It takes about at least about six months for the introduction of the vaccine against Omicron, the new variant. That's why I suggest people to have vaccination as soon as possible so that they have more neutralising anti-body in their system," he said.

Chui added that the survey showed the number of people who prefer the BioNTech jabs over Sinovac had increased significantly, as they become more concerned about the spread of variants.

About 86 percent of the respondents indicated that they prefer BioNTech, compared with just three percent who would opt or have opted for Sinovac.

"People know that the efficacy of the BioNTech vaccine is very high, about 91 percent in the real world data... Sinovac's efficacy is quite low, compared with BioNTech, talking about 55 to 60 percent," he said.

The society called on the government to consider procuring the Sinopharm vaccine – in addition to the current two – saying it has a relatively high efficacy rate.

RECENT NEWS

Ant International And Bank Of China Partner To Enhance Cross-Border Payment Connectivity

Ant International and Bank of China (Hong Kong) (“BOCHK”) announced a partnership which leverages BOCHK’s banking... Read more

BitGo Korea Gets Green Light For Virtual Asset Custody, Backed By SK Telecom

BitGo Holdings, Inc. (BitGo) announced that its subsidiary, BitGo Korea, Inc. (BitGo Korea), received its Virtual Asset... Read more

Webinar: When Account Takeover Moves Past Onboarding

Account takeover shows why fraud risk cannot be treated as an onboarding problem. Fraudsters are using stolen credentia... Read more

JCB To Trial Stablecoin Payments In Japan With Digital Garage And Lawson

JCB Co., Ltd. (JCB), Digital Garage, Inc. (Digital Garage), and Lawson, Inc. (Lawson) announced that they have jointly ... Read more

Bonnie Chan To Lead HKEX Until Feb 2030 After Securing Second Term

The HKEX Board of Directors has approved the renewal of the employment contract of Hong Kong Exchanges and Clearing Lim... Read more

Ripple Signs Its First Korean Regional Bank In Cross-Border Remittance Deal

Ripple, a blockchain-based enterprise solutions provider for traditional and digital finance, announced a partnership w... Read more